Navigation Links
Johnson & Johnson Highlights Strategies for Growth Through Differentiated Medicines, Transformational Pipeline and Global Product Launches
Date:5/26/2011

Strategies

Johnson & Johnson's pharmaceuticals business generated $22.4 billion in sales last year, 36 percent of the company's total revenue, and it ranks as the world's eighth largest pharmaceutical company and fifth largest biotech company.  The pharmaceuticals business saw over 6% operational growth in the first quarter of 2011 as new products contributed to growth and core brands delivered solid performance.  

Johnson & Johnson's pharmaceuticals business has taken a disciplined management approach to increasing its efficiency in order to invest in its pipeline and new product launches.  For example, the pharmaceuticals business has seen a significant increase in productivity over the last two years based on the ratio of sales per employee, and it continues investing in R&D at higher rates than its competitive set.

Ms. McCoy added, "The health care industry is undergoing dramatic change and with science evolving rapidly, we are well-positioned for the new demands, requirements, demographics and trends shaping the health care market."

With the pharmaceutical market at an estimated $850 billion* globally and expected to grow to more than $1 trillion by 2015, Ms. McCoy and other leaders will outline four strategies for growth for the company's pharmaceuticals business:

  • Deliver differentiated medicines – In recent years, the pharmaceuticals business has transformed its portfolio by expanding its leadership in immunology, deepened its expertise in oncology and entered vaccines.  The company's pharmaceuticals businesses are in the process of launching six significant new products between 2009 and 2011, some in multiple geographies.  Two of the new products are pending regulatory review in the European Union (EU), and two additional key compounds are in registration in key markets. Many of these products could represent significant advances
    '/>"/>

SOURCE Johnson & Johnson
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Johnson & Johnson to Provide Webcast Presentation of Tapentadol Phase 3 Clinical Data Presented at American Pain Societys Annual Meeting
2. Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Announces FDA Filings for Paliperidone Palmitate and INVEGA(R)
3. Simbionix and Johnson & Johnson LLC Announce Distribution Agreement at Russia and the CIS Countries
4. Johnson & Johnson Announces Support for Kohl-Grassley Physician Payments Sunshine Act of 2009
5. Boston Scientific and Johnson & Johnson Announce Settlement of Patent Disputes
6. Palomar to Commercialize FDA Cleared Over-The-Counter Home Use Wrinkle Treatment Laser Device Without Johnson & Johnson
7. U.S. Files Suit Against Johnson & Johnson For Paying Kickbacks to Nations Largest Nursing Home Pharmacy
8. EF Johnson Technologies Announces Third Quarter Results
9. Emerging Agents from Theravance/Astellas, Johnson & Johnson/Basilea and Forest/Astrazeneca/Takeda Will Drive Modest Growth in the MRSA Drug Market Through 2018
10. Johnson & Johnson to Participate in the 30th Annual Cowen and Company Health Care Conference
11. Two Johnson & Johnson Subsidiaries to Pay Over $81 Million to Resolve Allegations of Off-Label Promotion of Topamax
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Dec. 23, 2014  Lockton Dunning Benefits, the ... Companies, announced the addition of Vice President ... Lockton Dunning,s Pharmacy Consulting team, Excelsior Solutions. ... industry experience to the position.  Most recently, she ... at Diplomat Specialty Pharmacy, where she has held ...
(Date:12/24/2014)... Calif. , Dec. 23, 2014 In response ... Doctors, Association of Sierra Leone , Direct ... Leone for the treatment of local health workers ... While a new dedicated Ebola care center was constructed for ... the facility is not available for local Sierra Leonean health ...
(Date:12/22/2014)... Dec. 22, 2014  CytoSorbents Corporation (OTCQB:CTSOD), a ... blood purification technology to help fight deadly inflammation ... countries worldwide, today announced the appointment of Dr. ... as its Senior Vice President of Clinical Development, ... Di Russo is an accomplished pediatric ...
Breaking Medicine Technology:Kim Foerster Joins Lockton Companies 2First Ebola Treatment Unit for Local Health Workers Arrives in Sierra Leone 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 5
... 2012  The new product planning and development process is ... to cost constraints and competitive pressures. New product planning ... 2012 and beyond need an updated road map to ... To that end, Best Practices, LLC ...
... Mich., Jan. 6, 2012  Perrigo Company (Nasdaq: PRGO;TASE) today ... Papa will present at the 30th Annual J.P. ... 10:30 AM (PST) at the Westin St. Francis ... be webcast at the following link: http://jpmorgan.metameetings.com/webcasts/healthcare12/?sessionId=9bb4fd7d0105162325790 ...
Cached Medicine Technology:New Product Planning Excellence Services Program Provides Road Map for Clinical Development Success in the Pharmaceutical Industry 2Perrigo Company to Present at the 30th Annual J.P. Morgan Healthcare Conference 2
(Date:12/26/2014)... Viejo, California (PRWEB) December 26, 2014 Plugin ... announced the TransPack Volume 5 Plugin for Final Cut Pro ... manipulate a hard light tool to pull off an industry ... “When users get their hands on TransPack Volume 5, a ... Volume 5 is a set of over 50 Final Cut ...
(Date:12/26/2014)... December 26, 2014 Parker & ... the best in heating, cooling and plumbing contractor ... hour emergency services in 2014 with regard to ... that Arizona is known for its incredibly hot ... understands the intricacies and details of a wide ...
(Date:12/25/2014)... December 26, 2014 The report “TS-1 ... focuses on the current treatment landscape, unmet needs, current ... TS-1 is an anti-cancer drug which is typically used ... is also used for treating gastric cancer and pancreatic ... potassium. The drug was first approved in 1999 in ...
(Date:12/25/2014)... December 25, 2014 The short film “Color ... created in honor of a true 9/11 hero, Welles Remy ... festivals including the 24 hours of Nuremberg International Short Film ... , Actress, screenwriter and director Luciana Lagana ... film together with her husband, Gregory Graham - ...
(Date:12/25/2014)... Recently, LunaDress.co.uk has updated its blog to provide professional shopping ... of the models at LunaDress.co.uk come with big discounts, up to ... veil can turn out to be a most exciting memory and ... always bring surprise to a wedding. On the updated fashion blog, ... veils for a big day . , Going out with friends ...
Breaking Medicine News(10 mins):Health News:Today a new plugin was announced from Pixel Film Studios, TransPack Volume 5 for Final Cut Pro X 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2
... CHICAGO, Today America's Second Harvest -- The Nation's Food ... food banks and more than 20,000 food service agencies ... legislators in Washington D.C. begin to consider drafts of ... nutrition programs it supports, America's Second Harvest released The ...
... receiving requests from models, actors, dermatologists, skin care professionals ... Inc. recently launched the Bx Pro/Face line. Compared ... available, the Bx Pro/Face formula contains higher doses of ... being lost in one year. Bx Pro/Face further diminishes ...
... Avandia heated up Wednesday as experts pointed to studies linking ... study claimed rosiglitazone is safe. ,The GlaxoSmithKline study ... (NEJM) gave preliminary results of a four-year clinical study of ... heart attacks or death. ,Among the sub-group of ...
... the Chinese government published a five-year plan to intensify ... plan claims that illegal activities behind production and sale ... effectively contained in future. The Chinese government has been ... at home and abroad regarding the poor quality standards ...
... low levels of normal serum potassium in patients with heart ... was conducted by a team of researchers led by Ali ... ,As part of the study, researchers studied 1,187 pairs of ... who were balanced in all measured baseline covariates. The patients ...
... 2004, Christopher Woods, a 29-year old resident in New York, drank ... Pharmaceutical company. ,When he woke up ... away. He had to go for medical advice and for treatment ... ,Priapism is persistent, painful erection of the ...
Cached Medicine News:Health News:Hunger Awareness Day to Shed Light on Surprising Face of Hunger June 5 2Health News:Hunger Awareness Day to Shed Light on Surprising Face of Hunger June 5 3Health News:Controversy Spikes Over Anti-diabetes Drug Avandia 2Health News:China is Cracking Down on Food Safety 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: